^○Tomohiro Hayashi¹, Takamasa Nukui¹, Jin-lan Piao¹, Tomoyuki Sugimoto², Ryo Tanaka¹, Hiroaki Hirosawa¹, Noriyuki Matsuda¹, Ryoko Anada¹, Mamoru Yamamoto¹, Hirofumi Konishi¹, Nobuhiro Dougu¹, Yuji Nakatsuji¹ (1.Department of Neurology, Faculty of Medicine, University of Toyama, Japan, 2.Graduate School of Data Science, Shiga University)

^○Jun Tsugawa¹, Satoshi Kimura¹, Miho Yamada¹, Kouhei Nii², Ritsurou Inoue², Toshio Higashi², Yoshio Tsuboi³ (1.Fukuoka University Chikushi Hospital Stroke Center, Japan, 2.Fukuoka University Chikushi Hospital Department of Neurosurgery, 3.Fukuoka University School of Medicine Department of Neurology)

^○Masahiro Iijima¹, Yuki Fukami¹, Naohiro Mohri¹, Haruki Koike¹, Kohji Murakami², Hitoshi Nakagawa², Masahisa Katsuno¹ (1.Department of Neurology, Nagoya University, Japan, 2.Japan Blood Products Organization)

^○Takamasa Kitaoji¹, Yu-ichi Noto¹, Yukiko Tsuji¹, Yuta Kojima¹, Toshiki Mizuno¹, Masanori Nakagawa² (1.Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan, 2.North Medical Center, Kyoto Prefectural University of Medicine)

^○Yu-ichi Noto¹, Kohei Watanabe², Holobar Ales³, Takamasa Kitaoji¹, Yukiko Tsuji¹, Yuta Kojima¹, Fukiko Kitani-morii¹, Toshiki Mizuno¹, Masanori Nakagawa⁴ (1.Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan, 2.Faculty of Liberal Arts and Sciences, Chukyo University, 3.Faculty of Electrical Engineering and Computer Science, University of Maribor, 4.North Medical Center, Kyoto Prefectural University of Medicine)

^○Keiko Hatano¹, Kenta Orimo¹, Mizuki Ogura², Shingo Okabe¹, Tadao Ishida², Akatsuki Kubota³, Jun Shimizu³, Hideji Hashida¹ (1.Department of Neurology, Japanese Red Cross Medical Center, Japan, 2.Department of Hematology, Japanese Red Cross Medical Center, 3.Department of Neurology, The University of Tokyo)

^○Yuwa Oka^1,2,3, Kazuto Tsukita^4,5,6, Koji Tsuzaki^1,2, Naoko Uehara^1,2, Shinichi Wada¹, Naoko Takamatsu^1,7, Toshiaki Hamano^1,2 (1.Department of Neurology, Kansai Electric Power Hospital,, Japan, 2.Division of Clinical Neurology, Kansai Electric Power Medical Research Institute, Japan, 3.Department of Neurology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Japan, 4.Division of Sleep Medicine, Kansai Electric Power Medical Research Institute, 5.Department of Neurology, Graduate School of Medicine, Kyoto University, 6.Laboratory of Barriology and Cell Biology, Graduate School of Frontier Biosciences, Osaka University, 7.Department of Neurology, Tokushima University Hospital)

^○Shin Loong Soong¹, Li Ie Lau¹, Kenny Tan², Faiz Suhaimi³, Selvakumar Thankamony³, Gaik Bee Eow³ (1.RCSI & UCD Malaysia Campus (RUMC), Penang, Malaysia, 2.Loh Guan Lye Specialist Centre, Penang, Malaysia, 3.Department of Neurology, Penang Hospital, Penang, Malaysia)

^○Nagaaki Katoh¹, Ryuta Abe¹, Yusuke Takahashi¹, Satoshi Nakao¹, Ken Takasone¹, Tsuneaki Yoshinaga¹, Masahide Yazaki², Fuyuki Kametani³, Yoshiki Sekijima¹ (1.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan, 2.Institute for Biomedical Sciences, Shinshu University, 3.Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science)

^○Ryota Sato, Takashi Kanda (Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan)

^○Yoshiki Sekijima¹, L Obici², I Conceição³, M Polydefkis⁴, J Gillmore⁵, E Berber⁶, Mt White⁷, Mt Sweetser⁷, Jj Wang⁶, Jl Berk⁸ (1.Shinshu University School of Medicine, Matsumoto, Japan (presenting on behalf of the authors), Japan, 2.Fondazione IRCCS Policlinco San Matteo, Pavia, Italy, 3.Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal, 4.Johns Hopkins University, Baltimore, USA, 5.National Amyloidosis Centre, London, UK, 6.Former affiliation of Alnylam Pharmaceuticals, Cambridge, MA, USA, 7.Alnylam Pharmaceuticals, Cambridge, MA, USA, 8.Amyloidosis Center, Boston University, Boston, MA, USA)

^○Mitsuharu Ueda¹, D Adams², A González-duarte³, E Mauricio⁴, T Brannagan⁵, T Coelho⁶, J Wixner⁷, H Schmidt⁸, E Berber⁹, Mt Sweetser¹⁰, Mt White¹⁰, Jj Wang⁹, M Polydefkis¹¹ (1.Kumamoto University, Kumamoto, Japan (presenting on behalf of the authors), Japan, 2.National Reference Center for FAP (NNERF)/ APHP/ INSERM U 1195/ CHU Bicêtre, Le Kremlin Bicêtre, France, 3.Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico, 4.Mayo Clinic, Jacksonville, FL, USA, 5.Department of Neurology, Columbia University, New York City, NY, USA, 6.Hospital de Santo António, Porto, Portugal, 7.Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, 8.University Hospital Muenster, Muenster, Germany, 9.Former affiliation of Alnylam Pharmaceuticals, Cambridge, USA, 10.Alnylam Pharmaceuticals, Cambridge, USA, 11.Johns Hopkins University, Baltimore, USA)